Contact
 

The African AIDS Vaccine Initiative (AAVP) is recruiting for an Executive Director.  The description is attached below. 

IAVI has provided electronic access to its recently updated Vaccine Literacy (VaxLit) Toolkit. The VaxLit Toolkit is a comprehensive set of educational and training materials about AIDS vaccine development and clinical trials, developed in...

The NIH announced a new initiative to strengthen medical education in Sub-Saharan Africa, in collaboration with the President’s Emergency Plan for AIDS Relief (PEPFAR).  The program, called the Medical Education Partnership Initiative, is a...

The Medical Research Council launched a new scheme to support African Research Leaders. This is a highly prestigious award, jointly funded by the MRC and the UK’s Department for International Development (DfID), for non-clinical and clinical...

The Microbicides Media and Communications Initiative (MMCI), in partnership with Family Health International (FHI) and the Global Campaign for Microbicides (GCM), will launch the Communications Handbook for Clinical Trials, a practical guide...

AmfAR and TAG issued a brief, The Sound Investment: The Multiplier Effect of AIDS Research, which states that in FY2011 and future years, Congress must redress five years of flat funding for NIH by significantly increasing overall NIH...

In commemoration of the 5th annual National Women and Girls HIV/AIDS Awareness Day on March 10, 2010, NIAID Director, Dr. Anthony S.

The International AIDS Vaccine Initiative (IAVI) announced the appointment of David N. Cook as Executive Vice President and Chief Operating Officer. In this role, Cook will lead the senior management team, oversee IAVI’s operations and work...

The Canadian HIV Vaccine Initiative (CHVI) issued a statement on the decision of the Government of Canada and the Gates Foundation not to proceed with the pilot-scale HIV vaccine manufacturing facility in Canada. Visit the CHVI web site for...

A team of scientists at Oxford University and Nova Laboratories found a simple and inexpensive way of keeping vaccines stable even at tropical temperatures, researchers report in the journal Science Translational Medicine.

Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account